Innate Pharma S.A. (IPHA) Earnings
NASDAQ·Healthcare·Biotechnology
$1.77
+1.83%
Mkt Cap $150.90M
Next Earnings
In 96 daysThu, Sep 17, 2026
EPS Estimate
-$0.33
1 analysts
Revenue Estimate
$6.44M
Q4 2025: beat by +0.83% on EPS, +79.14% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$150.90M
P/E
—
Fwd P/E
—
P/S
39.66
Rev TTM
—
EPS TTM
-$0.54